At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic Conditions
NCT01931644 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 17667
Last updated 2024-04-18
Summary
We are the missing link in clinical trials, connecting patients and researchers seamlessly and conveniently using a mobile health platform to advance medical research. We make it easy for patients to contribute to research for medical conditions that matter most to them, regardless of their location or ability to travel.
Conditions
- All Diagnosed Health Conditions
- ADD/ADHD
- Alopecia Areata
- Ankylosing Spondylitis
- Asthma
- Atopic Dermatitis Eczema
- Beta Thalassemia
- Bipolar Disorder
- Breast Cancer
- Celiac Disease
- Cervical Cancer
- Chronic Inflammatory Demyelinating Polyneuropathy
- Chronic Kidney Diseases
- Chronic Obstructive Pulmonary Disease
- Colon Cancer
- Colorectal Cancer
- Crohn's Disease
- Cystic Fibrosis
- Depression
- Diabetes Mellitus
- Duchenne Muscular Dystrophy
- Endometriosis
- Epilepsy
- Facioscapulohumeral Muscular Dystrophy
- G6PD Deficiency
- General Anxiety Disorder
- Hepatitis B
- Hereditary Hemorrhagic Telangiectasia
- HIV/AIDS
- Human Papilloma Virus
- Huntington's Disease
- Idiopathic Thrombocytopenic Purpura
- Insomnia
- Kidney Cancer
- Leukemia
- Lung Cancer
- Lupus Nephritis
- Lymphoma
- Melanoma
- Multiple Myeloma
- Multiple Sclerosis
- Myositis
- Myotonic Dystrophy
- Ovarian Cancer
- Pancreatic Cancer
- Parkinson's Disease
- Polycystic Kidney Diseases
- Prostate Cancer
- Psoriasis
- Psoriatic Arthritis
- Rosacea
- Scleroderma
- Sickle Cell Anemia
- Sickle Cell Trait
- Sjogren's Syndrome
- Skin Cancer
- Spinal Muscular Atrophy
- Systemic Lupus Erythematosus
- Thrombotic Thrombocytopenic Purpura
- Trisomy 21
- Ulcerative Colitis
Sponsors & Collaborators
-
Sanguine Biosciences
lead INDUSTRY
Principal Investigators
-
Houman Hemmati, MD · Sanguine Biosciences
Eligibility
- Min Age
- 18 Years
- Max Age
- 100 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2013-07-31
- Primary Completion
- 2024-04-30
- Completion
- 2024-04-30
Countries
- United States
Study Locations
More Related Trials
-
Rheumatology Patient Registry and Biorepository
NCT04402086 ·Status: RECRUITING
-
A Phase 1/2a Study of DB-2304 in Healthy Adults and SLE Participants
NCT06625671 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
AB-101 in Combination With B-Cell Depleting mAb in Patients Who Failed Treatment for Class III or IV Lupus Nephritis or Other Forms of Refractory Systemic Lupus Erythematosus
NCT06265220 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
A Study of Skin and Systemic Biomarkers In Patients With Active Cutaneous Lupus Erythematosus And In Healthy Volunteers
NCT02034344 ·Status: COMPLETED
-
Lupus Immunosuppressive/Immunomodulatory Therapy or Stem Cell Transplant (LIST)
NCT00230035 ·Status: WITHDRAWN ·Phase: PHASE2
-
A Study to Assess the Safety and Clinical Activity of Azer-cel in Participants With B-cell Mediated Autoimmune Disorders
NCT06680037 ·Status: RECRUITING ·Phase: PHASE1
-
Study of the Predictors of the Course and Early Outcome of Patients With Systemic Lupus Erythematosus: Nature Versus Nurture
NCT00006134 ·Status: COMPLETED
-
Phase 2 Trial of Mesenchymal Stem Cells in Systemic Lupus Erythematosus (MiSLE)
NCT02633163 ·Status: COMPLETED ·Phase: PHASE2
-
Study of Epratuzumab in Systemic Lupus Erythematosus
NCT00383513 ·Status: COMPLETED ·Phase: PHASE2
-
Open-label Study of Epratuzumab in Serologically-positive Systemic Lupus Erythematosus Patients With Active Disease
NCT00660881 ·Status: COMPLETED ·Phase: PHASE2
-
Open-label Single-Center Study to Evaluate the Safety and Efficacy of Combining Rituximab and AB-101 in B-cell Associated Autoimmune Diseases.
NCT06581562 ·Status: RECRUITING ·Phase: PHASE1
-
T and B Cell Responses in Autoimmune Diseases
NCT01947036 ·Status: TERMINATED
-
Immune Ablation and Hematopoietic Stem Cell Support in Patients With Systemic Lupus Erythematosus: A Phase II Study
NCT00271934 ·Status: COMPLETED ·Phase: PHASE2
-
Biomarkers of Lupus Disease: Serial Biomarker Sampling in Patients With Active Systemic Lupus Erythematosus (SLE)
NCT00987831 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Autologous Stem Cell Transplantation for Refractory Systemic Lupus Erythematosus (ASSIST)
NCT00750971 ·Status: UNKNOWN ·Phase: PHASE2
-
Open Label Extension Study of Epratuzumab in Subjects With Systemic Lupus Erythematosus
NCT01408576 ·Status: COMPLETED ·Phase: PHASE3
-
Immunome Project Consortium for Autoinflammatory Disorders
NCT03919110 ·Status: COMPLETED
-
Molecular Diagnosis of Systemic Autoinflammatory Diseases
NCT05364294 ·Status: RECRUITING
-
Dose Ranging Study of Brentuximab Vedotin in Adults With Lupus
NCT02533570 ·Status: TERMINATED ·Phase: PHASE2
-
Treatment of Refractory Systemic Lupus Erythematosus by Allogeneic Mesenchymal Stem Cells Derived From the Umbilical Cord
NCT03562065 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
COVID-19 Booster Vaccine in Autoimmune Disease Non-Responders
NCT05000216 ·Status: TERMINATED ·Phase: PHASE2
-
Retrospective Medical Chart Review Study to Describe the Experience of SLE Patients Treated With Anifrolumab in the Early Access Programs.
NCT06046534 ·Status: COMPLETED
-
A Study to Evaluate the Efficacy and Safety of Obinutuzumab in Participants With ISN/RPS 2003 Class III or IV Lupus Nephritis
NCT04221477 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
A Study in Participants With Active Systemic Lupus Erythematosus With Inadequate Response to Glucocorticoids and ≥2 Immunosuppressants
NCT07175285 ·Status: RECRUITING
-
Phase 1 Study of Belimumab in Subjects With Systemic Lupus Erythematosus (SLE)
NCT00657007 ·Status: COMPLETED ·Phase: PHASE1
Entities
- Alopecia Areata
- Ankylosing Spondylitis
- Asthma
- Bipolar Disorder
- Breast Cancer
- Celiac Disease
- Cervical Cancer
- Chronic Inflammatory Demyelinating Polyneuropathy
- Chronic Obstructive Pulmonary Disease
- Colon Cancer
- Colorectal Cancer
- Crohn's Disease
- Cystic Fibrosis
- Depression
- Diabetes Mellitus
- Duchenne Muscular Dystrophy
- Epilepsy
- Facioscapulohumeral Muscular Dystrophy
- Hepatitis B
- HIV/AIDS
- Human Papilloma Virus
- Huntington's Disease
- Insomnia
- Kidney Cancer
- Leukemia
- Lung Cancer
- Lupus Nephritis
- Lymphoma
- Melanoma
- Multiple Myeloma
- Multiple Sclerosis
- Ovarian Cancer
- Pancreatic Cancer
- Parkinson's Disease
- Prostate Cancer
- Psoriasis
- Psoriatic Arthritis
- Sickle Cell Anemia
- Skin Cancer
- Spinal Muscular Atrophy
- Systemic Lupus Erythematosus
- Ulcerative Colitis